8-K: FONAR Receives Enhanced Take-Private Offer at $17.25 Per Share

FONAR Corporation's Special Committee has received a supplemental proposal from a group led by CEO Timothy Damadian to acquire all outstanding shares not currently owned for $17.25 per share in cash, representing a 27% premium.

Summary

• FONAR Corporation's Special Committee of the Board of Directors received a supplemental proposal letter dated July 17, 2025.
• The proposal is from a Proposed Acquisition Group led by Timothy Damadian, the company's Chief Executive Officer.
• The group proposes to acquire all outstanding capital stock of FONAR not currently owned by them for $17.25 per share in cash.
• This proposed price represents a premium of approximately 27% over the average closing price of the Common Stock for the 90 trading day period ending on June 30, 2025.
• The Special Committee, composed of independent and disinterested directors, will carefully review the supplemental proposal in consultation with independent financial and legal advisors.
• Shareholders are cautioned that the proposal is only an indication of interest and does not constitute a binding commitment, with no assurance that any agreement will be executed or the transaction consummated.

Sentiment

Score: 8

Explanation: The proposed take-private offer at a substantial premium is a strong positive for current shareholders, indicating potential for immediate value realization. However, the non-binding nature and uncertainty of completion temper the sentiment slightly.

Positives

• A take-private proposal has been received, potentially offering liquidity to shareholders.
• The proposed acquisition price of $17.25 per share in cash represents a significant premium of approximately 27% over the 90-day average closing price ending June 30, 2025.
• The Special Committee, composed of independent and disinterested directors, is reviewing the proposal to ensure it is in the best interest of all shareholders.

Negatives

• The proposal is only an indication of interest and does not constitute a binding commitment.
• There is no assurance that any agreement will be executed or that the proposed transaction, or any other transaction, will be approved or consummated.
• No agreement will be created unless definitive documentation is executed and delivered by the appropriate parties.

Risks

• The proposed acquisition is not a binding commitment and may not lead to a definitive agreement.
• There is no guarantee that the transaction will be approved or consummated.
• The Special Committee may determine that no such transaction will be effected, leading to the proposal being withdrawn or rejected.
• Shareholders face uncertainty regarding the completion of the proposed transaction.

Future Outlook

FONAR does not anticipate making any further public statements about this matter or the activities of the Special Committee unless and until it enters into a definitive agreement for a transaction or the Special Committee determines that no such transaction will be effected.

Management Comments

• The Special Committee will carefully review the supplemental proposal in consultation with independent financial and legal advisors to determine the course of action that is in the best interest of FONAR and all shareholders.
• No action is required by FONAR shareholders at this time.
• FONAR cautions its shareholders and others considering trading in FONARs securities that FONAR has only recently received the supplemental proposal letter and no decisions have been made with respect to FONARs response to the proposed transaction.
• The proposal constitutes only an indication of interest by the Proposed Acquisition Group and does not constitute a binding commitment.
• There can be no assurance that any agreement will be executed or that the transaction contemplated in the proposal or any other transaction will be approved or consummated.

Industry Context

FONAR Corporation is a pioneer in the MRI industry, incorporated in 1978 and going public in 1981, making it the first, oldest, and most experienced MRI company. Its signature product, the FONAR UPRIGHT Multi-Position MRI, offers unique weight-bearing scanning capabilities, differentiating it from conventional lie-down MRI scanners. The company's primary income and growth are driven by its diagnostic imaging management subsidiary, Health Management Company of America (HMCA), and it continues to innovate with new technology for visualizing cerebral hydraulics.

Corporate Governance

Related Party Transactions

• The Proposed Acquisition Group is led by Timothy Damadian, the company's Chief Executive Officer, making this a related-party transaction.

Stakeholder Impact

• Shareholders: Potential for immediate liquidity and a significant premium on their shares if the transaction is completed. Uncertainty exists until a definitive agreement is reached.
• Employees: No direct impact mentioned, but a take-private transaction could lead to future operational or structural changes.
• Customers: No direct impact mentioned.

Next Steps

• The Special Committee will carefully review the supplemental proposal.
• The Special Committee will consult with independent financial and legal advisors.
• The Special Committee will determine the course of action that is in the best interest of FONAR and all shareholders.
• FONAR will make further public statements only if a definitive agreement is entered into or if the Special Committee determines no such transaction will be effected.

Key Dates

Recommendation

Keywords

FONAR Corporation, FONR, Take-private, Acquisition proposal, Special Committee, Timothy Damadian, MRI, Medical imaging, Shareholder value, Corporate governance, Cash offer, Premium